Male Circumcision Against HIV Hukomboa
Increasing Uptake of Voluntary Medical Male Circumcision Among Men Aged 20-34 Years in Njombe & Tabora Regions, Tanzania: A Cluster Randomised Controlled Trial
1 other identifier
interventional
10,782
1 country
2
Brief Summary
Tanzania launched a National Strategy for scaling-up voluntary medical male circumcision in 2010, and aims to circumcise 2.8 million males by 2015. In September 2009, Jhpiego's Maternal and Child Health Integrated Program (MCHIP) launched a PEPFAR-funded voluntary medical male circumcision (VMMC) program which has circumcised over 110,000 males in Njombe and Iringa regions by June 2012. In line with the national strategy, the target age for the program was 10-34 years, but 80% of clients were aged 10-19 years. There is an urgent need to increase the proportion of older men (aged 20 years and above) who become circumcised, to have greatest impact on the HIV epidemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Feb 2014
Typical duration for not_applicable hiv
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2014
CompletedFirst Submitted
Initial submission to the registry
February 24, 2015
CompletedFirst Posted
Study publicly available on registry
March 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2017
CompletedOctober 6, 2017
October 1, 2017
1.2 years
February 24, 2015
October 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of intervention on proportion of male clients aged 20-34 years (ratio of the geometric mean proportion of clients aged 20-34 years in the 10 intervention facilities versus that in the 10 control facilities)
Cluster-level summary methods will be used to assess the impact of the intervention\[19\]. The primary outcome will be the unadjusted "prevalence ratio", estimated as the .
5-6 weeks of demand creation activities
Secondary Outcomes (1)
Comparison of population attending for circumcision with general male population (proportion of males reporting the below risk factors will be compared to proportion of males reporting the same in the 2010 Tanzania Demographic and Health Survey)
5-6 weeks
Study Arms (2)
Control
NO INTERVENTIONIndividuals receiving the standard Ministry of Health Package
Intervention
EXPERIMENTALIndividuals receiving the targeted demand creation strategy to increase adult men taking up VMMC
Interventions
Sites randomized to the intervention arm will receive all activities in the control arm, plus additional demand-creation communication messages that focus on the non-HIV benefits of VMMC and the voluntary nature of HIV testing prior to VMMC ii) use of already circumcised men from the community as auxiliary peer promoters, iii) separate waiting and group education areas for men aged 20 years and above during service delivery, iv) engagement of female partners in community-based demand creation and education and counselling about wound healing and post-circumcision abstinence.
Eligibility Criteria
You may qualify if:
- Sites
- an outreach VMMC health facility,
- a site selected by Jhpiego for outreach VMMC campaign,
- a site that has not had previous outreach services (to enable the results to be generalizable to future new outreach) or have not had VMMC outreach services in the previous 6 months, and
- physically distant from other potential study sites to minimise contamination (spill over) of activities in the intervention communities into control communities.
- The parent sites from different clusters must be at least 20km away from each other, regardless of whether they are randomised to be control or intervention sites.
- Clients
- Uncircumcised males
- given an informed consent to participate in the study
You may not qualify if:
- \) Circumcised males
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute for Medical Research, Tanzanialead
- London School of Hygiene and Tropical Medicinecollaborator
- Jhpiegocollaborator
- Centers for Disease Control and Preventioncollaborator
Study Sites (2)
Njombe
Njombe, Tanzania
Tabora
Tabora, Tanzania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
February 24, 2015
First Posted
March 3, 2015
Study Start
February 3, 2014
Primary Completion
May 4, 2015
Study Completion
February 28, 2017
Last Updated
October 6, 2017
Record last verified: 2017-10